Differential impact of lacunes and microvascular lesions on poststroke depression

Stroke

Volumn 40, Issue 11, 2009, Pages 3557-3562

  Santos, Micaela ^a   Gold, Gabriel ^b   Kövari, Enikö ^a   Herrmann, Francois R ^b   Bozikas, Vasilis P ^c   Bouras, Constantin ^a   Giannakopoulos, Panteleimon ^a,d  

^a Department of Psychiatry ^*  (Switzerland)

^b UNIVERSITY OF GENEVA MEDICAL SCHOOL   (Switzerland)

^c ARISTOTLE UNIVERSITY OF THESSALONIKI   (Greece)

^d University of Lausanne Medical Center   (Switzerland)

Author keywords

Behavioral neurology; Brain ischemia; Cerebral infarct; Neuropathology

Indexed keywords

ARTICLE; BASAL GANGLION; CEREBROVASCULAR DISEASE; DEPRESSION; HUMAN; LACUNE; NEUROPATHOLOGY; PRIORITY JOURNAL; STROKE; THALAMUS; VASCULAR LESION; WHITE MATTER;

AGED; AGED, 80 AND OVER; BRAIN INFARCTION; DEPRESSIVE DISORDER, MAJOR; FEMALE; FOLLOW-UP STUDIES; HUMANS; MALE; MICROCIRCULATION; PROSPECTIVE STUDIES; STROKE;

EID: 70350560777     PISSN: 00392499     EISSN: None     Source Type: Journal    
DOI: 10.1161/STROKEAHA.109.548545     Document Type: Article

References (58)

1. WHO. Stroke 1989. Recommendations on stroke prevention, diagnosis, and therapy. Report of the WHO task force on stroke and other cerebro-vascular disorders. Stroke. 1989;20:1407-1431.
2. Hackett ML, Yapa C, Parag V, Anderson CS. Frequency of depression after stroke: A systematic review of observational studies. Stroke. 2005; 36:1330-1340.
3. Whyte EM, Mulsant BH, Vanderbilt J, Dodge HH, Ganguli M. Depression after stroke: A prospective epidemiological study. J Am Geriatr Soc. 2004;52:774-778.
4. Carson AJ, MacHale S, Allen K, Lawrie SM, Dennis M, House A, Sharpe M. Depression after stroke and lesion location: A systematic review. Lancet. 2000;356:122-126.
5. Gabaldon L, Fuentes B, Frank-Garcia A, Diez-Tejedor E. Poststroke depression: Importance of its detection and treatment. Cerebrovasc Dis. 2007;24 Suppl 1:181-188.
6. Robinson RG, Shoemaker WJ, Schlumpf M, Valk T, Bloom FE. Effect of experimental cerebral infarction in rat brain on catecholamines and behaviour. Nature. 1975;255:332-334.
7. Robinson RG, Kubos KL, Starr LB, Rao K, Price TR. Mood changes in stroke patients: Relationship to lesion location. Compr Psychiatry. 1983; 24:555-566.
8. Naarding P, de Koning I, van Kooten F, Janzing JG, Beekman AT, Koudstaal PJ. Post-stroke dementia and depression: Frontosubcortical dysfunction as missing link? Int J Geriatr Psychiatry. 2007;22:1-8.
9. Robinson RG. Poststroke depression: Prevalence, diagnosis, treatment, and disease progression. Biol Psychiatry. 2003;54:376-387.
10. Robinson RG, Szetela B. Mood change following left hemispheric brain injury. Ann Neurol. 1981;9:447-453.
11. Hama S, Yamashita H, Shigenobu M, Watanabe A, Kurisu K, Yamawaki S, Kitaoka T. Post-stroke affective or apathetic depression and lesion location: Left frontal lobe and bilateral basal ganglia. Eur Arch Psychiatry Clin Neurosci. 2007;257:149-152.
12. Vataja R, Leppavuori A, Pohjasvaara T, Mantyla R, Aronen HJ, Salonen O, Kaste M, Erkinjuntti T. Poststroke depression and lesion location revisited. J Neuropsychiatry Clin Neurosci. 2004;16:156-162.
13. Brodaty H, Withall A, Altendorf A, Sachdev PS. Rates of depression at 3 and 15 months poststroke and their relationship with cognitive decline: The Sydney stroke study. Am J Geriatr Psychiatry. 2007;15:477-486.
14. Paolucci S, Gandolfo C, Provinciali L, Torta R, Toso V. The Italian multicenter observational study on post-stroke depression (DESTRO). J Neurol. 2006;253:556-562.
15. Bhogal SK, Teasell R, Foley N, Speechley M. Lesion location and poststroke depression: Systematic review of the methodological limitations in the literature. Stroke. 2004;35:794-802.
16. Bozikas VP, Gold G, Kövari E, Herrmann F, Karavatos A, Giannakopoulos P, Bouras C. Pathological correlates of poststroke depression in elderly patients. Am J Geriatr Psychiatry. 2005;13:166-169.
17. Alexopoulos GS, Meyers BS, Young RC, Campbell S, Silbersweig D, Charlson M. "Vascular depression" hypothesis. Arch Gen Psychiatry. 1997;54:915-922.
18. Alexopoulos GS, Murphy CF, Gunning-Dixon FM, Latoussakis V, Kanellopoulos D, Klimstra S, Lim KO, Hoptman MJ. Microstructural white matter abnormalities and remission of geriatric depression. Am J Psychiatry. 2008;165:238-244.
19. Cherr GS, Wang J, Zimmerman PM, Dosluoglu HH. Depression is associated with worse patency and recurrent leg symptoms after lower extremity revascularization. J Vasc Surg. 2007;45:744-750.
20. Herrmann LL, Le Masurier M, Ebmeier KP. White matter hyperinten-sities in late life depression: A systematic review. J Neurol Neurosurg Psychiatry. 2008;79:619-624.
21. Krishnan KR, Hays JC, Blazer DG. MRI-defined vascular depression. Am J Psychiatry. 1997;154:497-501.
22. Taylor WD, MacFall JR, Payne ME, McQuoid DR, Provenzale JM, Steffens DC, Krishnan KR. Late-life depression and microstructural abnormalities in dorsolateral prefrontal cortex white matter. Am J Psychiatry. 2004;161: 1293-1296.
23. Taylor WD, Macfall JR, Payne ME, McQuoid DR, Steffens DC, Provenzale JM, Krishnan KR. Orbitofrontal cortex volume in late life depression: Influence of hyperintense lesions and genetic polymorphisms. Psychol Med. 2007;37:1763-1773.
24. Association AP Diagnostic and statistical manual of mental disorders. Washington: American Psychiatric Association; 1994.
25. Hughes CP, Berg L, Danziger WL, Coben LA, Martin RL. A new clinical scale for the staging of dementia. Brit J Psychiat. 1982;140:566-572.
26. Gainotti G, Marra C. Determinants and consequences of post-stroke depression. Curr Opin Neurol. 2002;15:85-89.
27. Lammie GA, Brannan F, Wardlaw JM. Incomplete lacunar infarction (type Ib lacunes). Acta Neuropathol. 1998;96:163-171.
28. Jellinger KA. The pathology of ischemic-vascular dementia: An update. J Neurol Sci. 2002;203-204:153-157.
29. Vallet PG, Guntern R, Hof PR, Golaz J, Delacourte A, Robakis NK, Bouras C. A comparative study of histological and immunohistochemical methods for neurofibrillary tangles and senile plaques in Alzheimer's disease. Acta Neuropathol. 1992;83:170-178.
30. Goedert M, Jakes R, Vanmechelen E. Monoclonal antibody AT8 recognises tau protein phosphorylated at both serine 202 and threonine 205. Neurosci Lett. 1995;189:167-169.
31. Bussière T, Friend PD, Sadeghi N, Wicinski B, Lin GI, Bouras C, Giannakopoulos P, Robakis NK, Morrison JH, Perl DP, Hof PR. Ste-reologic assessment of the total cortical volume occupied by amyloid deposits and its relationship with cognitive status in aging and Alzheimer's disease. Neuroscience. 2002;112:75-91.
32. Gold G, Giannakopoulos P, Herrmann FR, Bouras C, Kövari E. Identification of Alzheimer and vascular lesion thresholds for mixed dementia. Brain. 2007;130:2830-2836.
33. Kövari E, Gold G, Herrmann FR, Canuto A, Hof PR, Michel JP, Bouras C, Giannakopoulos P. Cortical microinfarcts and demyelination significantly affect cognition in brain aging. Stroke. 2004;35:410-414.
34. Mehta CR, Patel NR. Exact interference in categorial data. Biometrics. 1997;53:112-117.
35. Steffens DC, Chung H, Krishnan KR, Longstreth WT Jr, Carlson M, Burke GL. Antidepressant treatment and worsening white matter on serial cranial magnetic resonance imaging in the elderly: The cardiovascular health study. Stroke. 2008;39:857-862.
36. Hervé D, Godin O, Dufouil C, Viswanathan A, Jouvent E, Pachai C, Guichard JP, Bousser MG, Dichgans M, Chabriat H. Three-dimensional MRI analysis of individual volume of lacunes in CADASIL. Stroke. 2009;40:124-128.
37. Gouw AA, van der Flier WM, Fazekas F, van Straaten EC, Pantoni L, Poggesi A, Inzitari D, Erkinjuntti T, Wahlund LO, Waldemar G, Schmidt R, Scheltens P, Barkhof F. Progression of white matter hyperintensities and incidence of new lacunes over a 3-year period: The Leukoaraiosis and Disability study. Stroke. 2008;39:1414-1420.
38. Jellinger KA, Attems J. Incidence of cerebrovascular lesions in Alzheimer's disease: A postmortem study. Acta Neuropathol (Berl). 2003;105: 14-17.
39. Roman GC, Erkinjuntti T, Wallin A, Pantoni L, Chui HC. Subcortical ischaemic vascular dementia. Lancet Neurol. 2002;1:426-436.
40. Simoni M, Pantoni L, Pracucci G, Palmertz B, Guo X, Gustafson D, Skoog I. Prevalence of CT-detected cerebral abnormalities in an elderly swedish population sample. Acta Neurol Scand. 2008.
41. Vermeer SE, Prins ND, den Heijer T, Hofman A, Koudstaal PJ, Breteler MM. Silent brain infarcts and the risk of dementia and cognitive decline. N Engl J Med. 2003;348:1215-1222.
42. Cummings JL. Frontal-subcortical circuits and human behavior. Arch Neurol. 1993;50:873-880.
43. Reed BR, Eberling JL, Mungas D, Weiner M, Jagust WJ. Frontal lobe hypometabolism predicts cognitive decline in patients with lacunar infarcts. Arch Neurol. 2001;58:493-497.
44. Snowdon DA, Greiner LH, Mortimer JA, Riley KP, Greiner PA, Markesbery WR. Brain infarction and the clinical expression of Alzheimer disease. The Nun study. JAMA. 1997;277:813-817.
45. Biran I, Chatterjee A. Depression with anosognosia following a left subcortical stroke. Clin Neurol Neurosurg. 2003;105:99-101.
46. Tang WK, Chan SS, Chiu HF, Ungvari GS, Wong KS, Kwok TC, Mok V, Wong KT, Richards PS, Ahuja AT. Poststroke depression in chinese patients: Frequency, psychosocial, clinical, and radiological determinants. J Geriatr Psychiatry Neurol. 2005;18:45-51.
47. Vataja R, Pohjasvaara T, Leppavuori A, Mantyla R, Aronen HJ, Salonen O, Kaste M, Erkinjuntti T. Magnetic resonance imaging correlates of depression after ischemic stroke. Arch Gen Psychiatry. 2001;58:925-931.
48. Gold G, Kövari E, Corte G, Herrmann FR, Canuto A, Bussière T, Hof PR, Bouras C, Giannakopoulos P. Clinical validity of a beta-protein deposition staging in brain aging and Alzheimer disease. J Neuropathol Exp Neurol. 2001;60:946-952.
49. Gold G, Kövari E, Herrmann FR, Canuto A, Hof PR, Michel JP, Bouras C, Giannakopoulos P. Cognitive consequences of thalamic, basal ganglia, and deep white matter lacunes in brain aging and dementia. Stroke. 2005;36:1184-1188.
50. de Groot JC, de Leeuw FE, Oudkerk M, Hofman A, Jolles J, Breteler MM. Cerebral white matter lesions and depressive symptoms in elderly adults. Arch Gen Psychiatry. 2000;57:1071-1076. (Pubitemid 30818876)
51. O'Brien JT, Firbank MJ, Krishnan MS, van Straaten EC, van der Flier WM, Petrovic K, Pantoni L, Simoni M, Erkinjuntti T, Wallin A, Wahlund LO, Inzitari D. White matter hyperintensities rather than lacunar infarcts are associated with depressive symptoms in older people: The LADIS study. Am J Geriatr Psychiatry. 2006;14:834-841.
52. Teodorczuk A, O'Brien JT, Firbank MJ, Pantoni L, Poggesi A, Erkinjuntti T, Wallin A, Wahlund LO, Gouw A, Waldemar G, Schmidt R, Ferro JM, Chabriat H, Bazner H, Inzitari D. White matter changes and late-life depressive symptoms: Longitudinal study. Br J Psychiatry. 2007;191: 212-217.
53. Sahlas DJ, Bilbao JM, Swartz RH, Black SE. Clasmatodendrosis correlating with periventricular hyperintensity in mixed dementia. Ann Neurol. 2002;52:378-381.
54. Udaka F, Sawada H, Kameyama M. White matter lesions and dementia: MRI-pathological correlation. Ann N Y Acad Sci. 2002;977:411-415.
55. Versluis CE, van der Mast RC, van Buchem MA, Bollen EL, Blauw GJ, Eekhof JA, van der Wee NJ, de Craen AJ. Progression of cerebral white matter lesions is not associated with development of depressive symptoms in elderly subjects at risk of cardiovascular disease: The PROSPER study. Int J Geriatr Psychiatry. 2006;21:375-381.
56. Ding Z, Preiningerova J, Cannistraci CJ, Vollmer TL, Gore JC, Anderson AW. Quantification of multiple sclerosis lesion load and brain tissue volumetry using multiparameter MRI: Methodology and reproducibility. Magn Reson Imaging. 2005;23:445-452.
57. Whyte EM, Mulsant BH. Post stroke depression: Epidemiology, patho-physiology, and biological treatment. Biol Psychiatry. 2002;52:253-264.
58. Gianotti G. Emotional disorders in relation to unilateral brain damage. In: Feinberg TE, Farah MJ, eds. Behavioral neurology and neuropsychology. New York: McGraw-Hill Companies Inc; 2003:725-734.